Relevance of Population-Based Cutoffs to Define Sarcopenia in Clinical Studies [0.03%]
人群基于的截断值在临床 sarcopenia 诊断中的适用性分析
Shweta A Singh,Kaushal Madan,Ruchi Rastogi et al.
Shweta A Singh et al.
Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entity in Oblivion [0.03%]
失代偿期肝硬化的特发性高钙血症：重新审视一个被遗忘的实体
Divya C Ragate,Sunil Taneja,Akash Roy et al.
Divya C Ragate et al.
Hypercalcemia is a rare metabolic abnormality seen in patients with cirrhosis and is usually considered a paraneoplastic manifestation of hepatocellular carcinoma. Idiopathic hypercalcemia in cirrhosis is a diagnosis of exclusion, which is ...
Unusual Presentation of Systemic Lupus Erythematosus in a Young Male: A Case Report [0.03%]
一例年轻男性系统性红斑狼疮的不典型表现：病例报告
Dibya L Praharaj,Bipadabhanjan Mallick,Preetam Nath et al.
Dibya L Praharaj et al.
Hepatic involvement in systemic lupus erythematosus (SLE) is common but described infrequently. Liver is usually never the primary organ to be affected in lupus. Again hepatic involvement probably does not carry much prognostic importance t...
Hemorrhage and Rupture of an Unusual Benign Liver Lesion in Pregnancy: A Case Report [0.03%]
妊娠期罕见良性肝脏病变出血并破裂一例报告
Ayushi Agarwal,Danny Joy,Prasenjit Das et al.
Ayushi Agarwal et al.
Liver rupture in pregnancy is an acute condition with significant risk to the mother and fetus. It is known to occur with tumors such as hepatic adenoma, infective causes such as abscess, granulomatous diseases, and parasitic infections, an...
Sepsis Following Liver Biopsy in a Liver Transplant Recipient: Case Report and Review of Literature [0.03%]
肝移植受者的肝脏活检后全身性脓毒症病例报道及文献复习
Lokesh Agrawal,Sachin Jain,Kumble S Madhusudhan et al.
Lokesh Agrawal et al.
Percutaneous liver biopsy is a relatively safe procedure with low complication rates. Infections following liver biopsy are uncommon and can lead to a poor outcome. There are limited data on liver biopsy-related infections among liver trans...
Narendra S Choudhary,Neeraj Saraf,Sanjiv Saigal et al.
Narendra S Choudhary et al.
The survival of liver transplantation (LT) recipients has been improved remarkably in short-term. The major causes of mortality in long-term include nonimmunological causes such as cardiovascular, de novo malignancy, chronic kidney disease,...
What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease? [0.03%]
当前非酒精性脂肪肝疾病的药物治疗措施有哪些？
Deepu David,Chundamannil E Eapen
Deepu David
Of the currently available drugs tested to treat nonalcoholic fatty liver disease (NAFLD), the most efficacious drugs are pioglitazone (an insulin sensitizer) and vitamin E (an antioxidant). By targeting insulin resistance, the key pathogen...
Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study [0.03%]
采用雷迪帕韦和索非布韦治疗慢性丙型肝炎3型的疗效观察研究
Gulzar A Dar,Ghulam N Yattoo,Ghulam M Gulzar et al.
Gulzar A Dar et al.
Objective: Sofosbuvir/ledipasvir (SOF/LED) is recommended for treatment of genotypes 1, 4, 5 and 6. Despite some preliminary data from the ELECTRON-2 trial regarding use of SOF/LED combination in chronic hepatitis C genot...
Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation [0.03%]
细胞衰老、维生素D缺乏及潜在保护作用与非酒精性脂肪肝疾病的研究
Hasen A Al-Ghamdi,Fayza F Al Fayez,Abdulhadi I Bima et al.
Hasen A Al-Ghamdi et al.
Background: Nonalcoholic fatty liver disease (NAFLD) is a pathological process characterized by excessive hepatic fatty deposition with possible involvement of vitamin D deficiency and cellular senescence. The aim of this...